The latest announcement is out from Brainstorm Cell Therapeutics ( ($BCLI) ). On November 10, 2025, BrainStorm Cell Therapeutics entered into a ...
AM ET$20 Million in New Financing Completed Subsequent to Quarter-EndDe-SPAC Liabilities Reduced by Over 80% Since Fiscal 2024Stockholders’ Equity Positive at $6.9 MillionThird Correspondent Clearing ...
Q3 2025 Earnings Call Transcript November 13, 2025 Operator: Good afternoon. Thank you for attending today’s Q3 2025 Marchex ...
Total Revenue of $77.7 million, an increase of approximately 15% quarter-over-quarterNet Income of $1.3 millionRecord Adjusted EBITDA of $56.3 ...
Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo,” “Zeo Energy,” or the “Company”), a Florida-based provider of residential solar and commercial long-duration energy-storage solutions, today reported financial ...
Cost of revenues for the nine months ended September 30, 2025 totaled $7.9 million compared to $11.4 million in the same period last year. The decrease was primarily due to a decrease in jet card and ...
Revenue of $2.8 Million for Q3 2025, up 163% from Q3 2024 Gross Profit of $2.3 Million for Q3 2025, a 213% increase from Q3 2024; Gross Margin Expanded to 81.7% in Q3 2025, a 1,302 BPS Increase ...
Accelsius recently secured strategic investment from Johnson Controls and introduced its NeuCool® MR250 system; pipeline of opportunities now exceeds $1 billion AeroFlexx delivered 5th consecutive qua ...
Received FDA Fast Track designation for stenoparib in advanced ovarian cancer Reported landmark median overall survival now exceeding 25 months in ongoing Phase 2 trialAdvanced DRP® platform through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback